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Abstract
Background
Whole-body vibration (WBV) is a method utilizing vibrating platforms to expose individuals
to mechanical vibration. In its various applications, it has been linked to improved muscular,
skeletal, metabolic, or cognitive functioning, quality of life, and physiological parameters
such as blood pressure. Most evidence concerning WBV is inconclusive and meta-analytical
reviews may not readily produce insights since the research has a risk of misunderstandings
of vibration parameters and incomplete reporting occurs. This study aims at laying an empir-
ical foundation for reporting guidelines for human WBV studies to improve the quality of
reporting and the currently limited comparability between studies.
Method
The Delphi methodology is employed to exploit the integrated knowledge of WBV experts to
distil the specific aspects of WBV methodology that should be included in such guidelines.
Over three rounds of completing online questionnaires, the expert panel (round 1/2/3: 51/
40/37 experts respectively from 17 countries with an average of 19.4 years of WBV research
experience) rated candidate items.
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Results
A 40-item list was established based on the ratings of the individual items from the expert
panel with a large final consensus (94.6%).
Conclusion
The final consensus indicates comprehensiveness and valuableness of the list. The results
are in line with previous guidelines but expand these extensively. The present results may
therefore serve as a foundation for updated guidelines for reporting human WBV studies in
order to improve the quality of reporting of WBV studies, improve comparability of studies
and facilitate the development of WBV study designs.
Introduction
Whole-Body Vibration (WBV) has received increasing attention in the field of physical, physi-
ological, and psychological rehabilitation [1–3]. WBV is a method utilizing vibrating platforms
(i.e., training devices) to expose the individuals’ whole body to vibration (usually with a fre-
quency between 5–60 Hz, depending on the device). This technique was originally aimed at
improving physical, muscular, and skeletal functioning [4–6], but has been employed for more
widespread applications since. So, the focus lies on WBV as a training or treatment method,
which must be distinguished from detrimental vibrations that people may be exposed to dur-
ing transportation or in occupational settings [7].
In its original application, the short- and long-term effects on physical functioning within
different scientific fields including medicine and movement sciences were examined [8–10].
More recently, WBV was also evaluated for its effects on, among others, blood pressure [11],
body mass [12,13], pulmonary function [14], quality of life [15] and cognitive functioning
[16–18]. WBV research in clinical settings is complemented by evidence from animal studies
[19–22]. With these new applications, the field of WBV research became more extensive, lead-
ing to (1) an increasing number of studies, (2) new and additional outcome measures, (3) fur-
ther methodological differences regarding devices, vibration parameters and research designs
used [23], and ultimately, (4) growing interdisciplinarity.
Across all applications of WBV in the various research fields, the evidence concerning its
effects on various functions has been inconsistent (e.g., see these reviews [6,8,10,24–29]).
Based on the inconclusive evidence within the different fields, no firm conclusions about the
effects of WBV training machines can be drawn as of now. More high-quality studies with
improved methodology [30] and complete and correct reporting with sufficient detail may
help to receive greater insight into the effects of WBV. Such studies can form the basis for
future meta-analytic studies [31] in order to identify modulating factors of WBV effects and,
ultimately, to identify optimal settings.
WBV regimes are defined by several technical components. Essential vibration parameters
include, but are not limited to, vibration frequency, amplitude or acceleration, and duration
[1,6,23,32]. These parameters are commonly reported inaccurately or completely omitted
from study reports [32] and can be subject to misunderstandings because of inconsistent ter-
minology (e.g. amplitude vs. peak-to-peak amplitude vs. peak-to-peak displacement) and lack
of information how these parameters were assessed [1,32]. Thus, misunderstandings or omis-
sions may not be readily apparent and may be included in published work. Based on the inter-
disciplinarity of WBV research, coherent terminology may be difficult to attain [32]. Yet,
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omitting important information or using vibration-specific terms interchangeably may lead to
inaccurate conclusions and will preclude high-quality study designs, their replicability, the
reporting of results, the comparability between studies, and the ability to explain inconsisten-
cies [1]. Therefore, complete and correct use of terminology is essential to ensure high-quality
reporting, as well as increasing the possibility and validity of comparing findings (meta-analy-
ses or systematic reviews). The possibility that these consistencies lead to the incomparability
of studies urges the consideration of consistent reporting.
As a consequence of these issues and to achieve a deeper understanding of the possible
effects of WBV, complete, consistent, and correct reporting is vital. A common manner to
ensure consistent reporting is the adherence to standardized reporting of research. The
EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network [33]
provides reporting guidelines such as the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) or the Consolidated Standards of Reporting Trials (CONSORT)
statement [34,35]. These statements identify key characteristics of any high-quality
publication.
Adherence to already existing general reporting guidelines, like CONSORT, is not sufficient
to ensure high-quality reporting in the field of WBV since the guidelines are not specific
enough to ensure complete, consistent, and correct reporting. The inherent technical compo-
nents of WBV and their susceptibility to misunderstandings, the large variation in devices,
parameter settings, and its applications require tailored guidelines. Therefore, instead of fol-
lowing only the CONSORT statement, new guidelines applicable to WBV research should be
adopted. Ideally, these guidelines will function as an addition to the CONSORT statement and
apply to all research utilizing WBV.
Previous efforts towards developing reporting guidelines specific to WBV research specified
reporting recommendations for WBV studies and defined and explained the physical princi-
ples of WBV (Rauch and colleagues [1], representing the International Society of Musculoskel-
etal and Neuronal Interactions). The recommendations were based on suggestions by experts,
but suggestion collection and the decision process behind selecting suggestions for the recom-
mendations are unclear. In addition, recent developments in the field of WBV research (e.g.,
new outcome measures, changes of devices, animal or cell culture studies) are not
incorporated.
The EQUATOR Network published recommendations on establishing new reporting
guidelines [36] and provides a platform for guidelines to increase their impact. In order to
encourage the development of guidelines when needed, the Network recommends that report-
ing guidelines should (1) include a range of stakeholders with expertise, (2) generate a list of
items through, for example, a Delphi consensus study, followed by (3) meetings of the execu-
tive group to discuss items or additional information which should be included [36].
Unlike prior publications initiating reporting guidelines or explanations of terminology
[1,6,32], systematically obtained consensus between WBV experts about the crucial aspects of
reporting human WBV research can lay the foundation for reporting guidelines. These guide-
lines should be widely accepted by the scientific community, can be used in all disciplines
using WBV, and follow the recommendations of the EQUATOR Network. Thus, the aim of
the present study is to commence the development of such reporting guidelines. The aim is
not to collect aspects of studies relevant to reporting research which are outlined in general
reporting guidelines (e.g., the CONSORT statement) not specific for WBV research (e.g., sam-
ple size, age of participants, type of study). The final reporting guidelines, which will be pre-
dominantly based on the present study and finalized by the executive group, will act as an
addition to these general reporting recommendations. An overview of the background of the
14 members of the executive group can be found in the supporting information (S1 File).
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The Delphi consensus methodology is utilized to inquire and collect the opinion and
knowledge of experts in the field from various backgrounds in the present study. This complies
with the recommendations of the EQUATOR Network, is a first step in the process of develop-
ing reporting guidelines for WBV research on humans, and uses the prior publication by
Rauch et al. [1] as a starting point.
Method
Delphi consensus methodology
The present study utilized the Delphi method. This method is a structured process to gather
information about a certain topic from a relevant group of people or experts [37]. It is based
on the assumption that the combination of opinions from various individuals lies closer to the
truth than the opinion of one person alone [38]. The Delphi method generally includes several
rounds during which the opinion of experts is inquired in a structured, yet interactive, manner
[39]. Throughout these rounds, controlled feedback is given to gain the most reliable consen-
sus of a panel of experts. This allows re-evaluation of prior responses and is thought to produce
trustworthy and reliable information. Building on the knowledge of the participants, the result
reflects their insights and opinions [40].
For the purposes of this study, a modified Delphi method of three rounds was employed to
gain an understanding about which aspects should be included in reporting guidelines for
human WBV studies. An overview of the rounds is given in Table 1 and the full instructions
and questionnaires can be found in the supporting information (S2 File). If necessary, more
rounds would be added during the progress of the study. Instead of the traditional Delphi
approach of starting the first round with open-ended questions [41], the first round in the
present study was modified to begin with a pre-selected list of items. It has been deemed
acceptable to modify the first round if it is based on literature and prior knowledge; is a com-
mon approach to the first round [41,42] and may increase response rate [43]. The This list of
items in the present study was constructed by means of a literature review, the previous recom-
mendations by Rauch et al [1] and related publications [6,23,32], experience of the authors,
and a discussion during the second conference of the World Association of Vibration Exercise
Experts (WAVEX; August 2018, Groningen, The Netherlands).
Based on the differences between animal and human research [44], the present study will
focus on WBV studies with human subjects only. A separate Delphi study will be conducted to
initiate reporting guidelines for animal and cell culture studies.
The rounds were conducted consecutively starting in February 2019 and the conclusion of
the last round in May 2019. The panel members were asked to complete each questionnaire
within three weeks. A weekly reminder to participate in the current round was sent to the
experts who did not complete the questionnaire yet. In the first round, potential panel experts
who are members of the WAVEX received an additional reminder to participate from the
board of the association after two weeks. All questionnaires were created with the online
Table 1. Overview of the Delphi rounds for the establishment of reporting guidelines in human WBV studies.
Round 1 • Panel members indicate whether pre-selected items of importance should commonly be reported
• Panel members suggest additional items of importance
Round 2 • Panel members receive structured feedback of the previous round
• Panel members indicate (dis)agreement to all items including the additionally suggested aspects
Round 3 • Panel members indicate (dis)agreement on the agreed-upon list of the previous rounds
• In case of disagreement, panel members specify changes required to agree with the list of aspects
https://doi.org/10.1371/journal.pone.0235905.t001
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survey software Qualtrics (Version 02/2019-05/2019 of Qualtrics; Copyright © 2019 Qualtrics;
Provo, UT, USA [45]) and distributed via Qualtrics by e-mail. This software additionally
ensured anonymous data collection throughout the whole study process.
The responses to the individual questionnaires were treated confidentially and the study
was approved by the Ethical Committee Psychology (ECP) affiliated to the University of Gro-
ningen, the Netherlands on 20/12/2018 (ref. no.; 18211-O).
Criteria regarding consensus achievement
Consensus about the aspects which should be included in reporting guidelines was is defined
as an agreement (yes, of importance to report) of at least 70% [46,47] while the disagreement
rate [48,49] (no, not important to report) is below 20% prior to the start of the study (see
Table 2). An agreement of 20% or below and a disagreement of 20% or above by the expert
panel is regarded as judging the item irrelevant. In case items were neither agreed nor dis-
agreed upon (below 70% of agreement and below 20% of disagreement or agreement above
70% and disagreement above 20%) or fall directly on the set criteria (e.g., an agreement of
exactly 20%), the items are named as ‘optional items’ in the final list of aspects of the present
study, which may be valuable in certain studies, as automatic exclusion may not be justified
[50]. These criteria were set by the executive group after consulting the literature of Delphi
studies and were judged to reasonably indicate consensus. Yet, based on the lack of agreement
about the definition of consensus [41,46], these values are to be seen as indicative of agreement
and not as an absolute judgement.
The results are analyzed quantitatively with: (1) Krippendorff’s alpha to estimate overall
agreement per round [51–53]; (2) the McNemar χ2-test to estimate stability of ratings between
round 1 and 2 [46,54]; (3) and Cohen’s Kappa to estimate the agreement between round 1 and
2 per item [55,56]. These estimates can be found in the supporting information (S3 File) since
violations of the assumptions of these estimates may reduce their validity.
Participants and recruitment
Suitable panel members with expertise of WBV from any scientific discipline making use of
WBV in human studies are essential to the present study. The inclusion criteria were designed
to ensure the high expertise of possible panel members. Thus, the inclusion criteria were the
following: (1) potential panel members must be willing to take part in the study and (2) have at
least two English, scientific (peer-reviewed) publications utilizing WBV with human partici-
pants. Exclusion criteria were: (1) one English scientific (peer-reviewed) publication utilizing
WBV with human participants and (2) if two or more scientific (peer-reviewed) publications
were published but in a language other than English (i.e., only no or one English peer-reviewed
publications) possible experts were excluded. Experts were identified through membership in
the WAVEX (https://internationalwavexmeeting.wordpress.com/), publications determined
via the scientific databases PubMed, PsycInfo, and Web of Science, and by recommendations
of members of WAVEX. Based on this a list of potential experts was compiled and invitations
Table 2. Overview of consensus criteria specifying the agreement-rates and corresponding disagreement-rates.
Consensus of Agreement-Rate Disagreement-Rate
-Important to report �70% �20%
-Not important to report �20% �20%
Optional item >70% >20%
20% - 70% �20%
https://doi.org/10.1371/journal.pone.0235905.t002
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to participate in the study were sent to them. Additionally, the experts who received an invita-
tion had the opportunity to recommend further experts which could take part in the study.
In total 136 experts were contacted. Fifty-six of these opened and filled in parts of the first
questionnaire (41.2% response rate). Fifty-one of these 56 participants completed the question-
naire (51/56 = 91.1% completion rate). The expert panel consisted of the 51 participants who
completed the first questionnaire and only these experts were contacted in the subsequent
round. In the second round, 40 panel members completed the survey (78% response rate).
Only the experts who completed round 2 were invited to the third round. Thirty-seven of
these 40 experts completed round 3 (92.5% response rate).
Materials and procedure
An overview of the procedure of the present study is given in Fig 1 and the full instructions
and questionnaires of all three rounds can be found in the supporting information (S2 File).
Round 1. The first round had two aims: (1) to receive an initial rating whether the pre-
determined items should be included in guidelines concerning WBV studies with humans and
(2) to collect suggestions of additional aspects the experts see as relevant. In the beginning of
this round, the expert panel members received information about the aim of the study and,
after giving informed consent, were asked to answer several general demographic questions.
In addition to age and gender, participants also indicated their highest completed education,
academic background and position, years of experience with research and clinical work, the
current distribution of their time (research/clinical/other), years of experience with WBV in
research and clinical settings, and number of published studies utilizing WBV.
After completing the short demographic questionnaire, the experts were presented with the
pre-determined items of importance. These 48 pre-determined items were separated into four
categories: information about the (1) vibration, (2) device, (3) administration, and (4) partici-
pants. The experts were asked to indicate whether they agree (‘yes’), do not agree (‘no’), or are
neutral (‘neutral/ don’t know’) about the importance of each specific item when reporting
human WBV studies. After each block, the experts had the opportunity to suggest additional
items and add questions or comments.
Two open questions were included (item 6 and 36). If experts agreed with item 6 (reporting
how vibration parameters are measured), they were asked to suggest how the measurements
should be completed. Similarly, if experts agreed with item 36 (reporting of participants
subjective experiences during WBV), they were asked to list the, in their opinion, relevant
experiences.
Fig 1. Flowchart of the Delphi study building towards reporting guidelines in human WBV studies. ‘n’ refers to
the number of items in each category.
https://doi.org/10.1371/journal.pone.0235905.g001
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Round 2. The aim of the second round was twofold. First, the experts were asked to indi-
cate their judgement about the items of the first round, while taking the first rounds ratings of
the panel into account. Hence, the experts re-evaluate their initial responses to the items in
light of their fellow experts’ opinion. This process is thought to be crucial to establish consen-
sus, as convergence of the individual opinions occurs [57]. Second, the additionally suggested
items and the results of the two open questions of the first round were presented to the experts.
Similar to the pre-determined items, the experts’ judgement on whether to include these items
in reports of human WBV studies was inquired.
Round 3. Similar to round 2, the items with consensus (agreement of at least 70% while
the disagreement rate is below 20%) regarding their importance to report, along with their rat-
ings of the second round, were presented.
The aim of the third round was to seek the experts’ agreement on the final list of items. The
panel members were asked to indicate agreement (yes/no) with the whole agreed-upon list
based on the previous rounds (see Fig 1). It was pointed out to the experts that not all items
may generally apply to each WBV study. However, items may still be relevant for particular
studies. In case of disagreement, the experts were asked to specify the reason for disagreement,
i.e., which aspect they disagree with.
Results
Round 1
Sample characteristics. Table 3 gives an overview of the demographic characteristics of the
51 expert panel members. 41.2% of the experts were female and the experts’ age was distributed
roughly equally across age groups with a mean of M = 46 years (SD = 10.4 years) ranging from 27
to 68 years. Most experts obtained a PhD (n = 30) and fewer a master’s degree (n = 4) or a profes-
sorship (n = 17) and had an average of 18 years of research experience and 11 years of clinical
experience (Table 3). The panel experts were located in 17 different countries. Various academic
backgrounds were reported, including medicine, engineering, physiotherapy, psychology, and
movement sciences. The expert panel reported an average of 11 publications utilizing WBV with
humans ranging from 2 to 40. Additionally, 37 experts reported clinical experience with WBV.
Agreement on pre-determined items. The ratings of the pre-determined list can be
found in Table 4. For the first category information about the vibration 14 out of 16 items had an
agreement rating of at least 70% (items 1–14). For item 15 (report the accuracy of vibration param-
eters), 68.6% of the experts were in favor of reporting the item. The remaining experts responded
‘neutral/do not know’ (23.5%) rather than ‘no’ (7.8%). For item 16 (which acceleration (in RMS)
occurs), 37.3% of the experts were in favor of reporting. More than 20% of the experts voted
against reporting this item, while 39.2% did not make a definite decision (‘neutral’).
For the items referring to the information about the device, four of six items were agreed
upon (items 17–20). The two items of no-consensus; item 21 (how the energy is generated (e.g.
direct mechanical transmission or electromagnetic transmission) as this can influence the perfor-
mance of the device) and item 22 (how the energy is generated the size of the vibration platform)
had a higher rating of ‘neutral/do not know’ than favoring against reporting it.
Information about the administration items were generally agreed upon for 14 of the 16
items (item 23–36 with an agreement of 70% or higher). For item 37 (reporting the location of
the intervention) and 38 (reporting the conditions of the test room) most experts not in favor
voted against reporting these items.
Five of the ten items concerning information about the participants were agreed upon
(items 39–43). For item 44 (how it is assured that neck and head are not negatively affected by
the vibration) and 47 (whether possible glasses were disturbing during the vibration), most experts
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not in favor of reporting responded with ‘neutral/do not know’. Most of the remaining experts
voted against reporting item 45 (the participants' clothing during the WBV), 46 (skin and muscle
perfusion during the WBV), and 48 (whether the participants wore glasses during WBV).
All answers regarding the two open questions can be found in the available dataset. For
item 6 (how should vibration parameters be measured), the use of an accelerometer was sug-
gested 24 times. Other suggestions were brought forward three times or less. These answers
were rated for their importance in the second round of the study (see Table 5).
Six responses to item 39 (which subjective experiences of WBV should be reported) were sug-
gested at least four times. These items are (1) level of pain, (2) dizziness, (3) fatigue, exhaustion,
and/ or tiredness, (4) tingling, itching, and/or burning sensations, (5) perceived effort or exer-
tion, (6) experiences of (dis)comfort. Other suggestions were brought forward three times or
less and are included in the available dataset.
Suggested items. A list of additionally suggested items and comments for each of the four
categories are included in the dataset. The first part of the questionnaire regarding information
about the vibration elicited several comments and additional items.
Table 3. Demographic characteristics of the expert panel.
Round 1 Round 2 Round 3
N 51 40 37
Age (in years, M ± SD) a 45.8±10.4 47.1±10.3 46.6±10.3
Gender (female/male) 21/30 15/25 13/24
Geographic location
Brazil 16 10 9
France 3 2 2
Germany 6 6 6
Italy 5 5 5
Spain 3 2 2
The Netherlands 4 3 3
USA 4 4 3
Other 10 b 8c 7d
Academic background
Engineering 10 8 8
Exercise physiology 3 3 2
Medicine 9 7 7
Movement/Health/Sport sciences 11 10 9
Physical therapy 16 10 9
Psychology 2 2 2
Academic degree/position (MSc/ PhD/ Prof) 4/30/17 1/23/16 1/21/15
Research work experience (in years, M ± SD) 18.1±10.7 19.7±10.7 19.4±10.6
Clinical work experience (in years, M ± SD) 11.5±10.1 11.2±9.9 11.6±9.9
Distribution of work time (in %, M ± SD)
Clinical work 17.9±24.4 17.3±23.3 17.7±23.6
Research 48.0±23.5 48.1±22.8 49.3±23.1
Other 34.1±24.9 34.5±24.5 32.9±23.8
Number of publications utilizing WBV (M ± SD) 11.4±10.2 12.02±10.9 11.6±11.2
Clinical experience with the use of WBV (yes/no) 37/14 31/9 30/7
a two non-responses; one expert each from Australia b, c, d, Belgium b, c, Canada b, c, d, Colombia b, c, d, Finland b, c, d,
New Zealand b, c, d, South Africa b, c, d, Switzerland b, United Arab Emirates b, United Kingdom b, c, d.
https://doi.org/10.1371/journal.pone.0235905.t003
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Table 4. Pre-determined items of importance when reporting human WBV studies and their importance rating of round 1 and 2.
Round 1 Round 2
Item
Number
When considering human
studies using whole-body
vibration is it important to
report. . .
Rating
Yes/
Neutral/
No
Agreement
(% of yes)
Disagreement
(% of no)
When considering human
studies using whole-body
vibration is it important to
report. . .
Rating
Yes/
Neutral/
No
Agreement
(% of yes)
Disagreement
(% of no)
Information about vibration Information about vibration
1 . . .which frequency (Hz) is
used?
51/0/0 100.0 0.0 . . .which frequency (Hz) is
used?
39/0/1 97.5 2.5
2 . . .whether the frequency (Hz)
is constant or variable?
50/1/0 98.0 0.0 . . .whether the frequency
(Hz) is constant or variable?
37/0/3 92.5 7.5
3 . . .the type of vibration (i.e.
synchronous, side-alternating,
other)?
49/0/2 96.1 3.6 . . .the type of vibration (i.e.
synchronous, side-alternating,
other)?
40/0/0 100.0 0.0
4 . . .the units of the vibration
parameters?
48/1/2 94.1 3.9 . . .the units of the vibration
parameters?
40/0/0 100.0 0.0
5 . . .the amplitude of the
vibration (in mm)?
48/2/1 94.1 2.0 . . .the amplitude of the
vibration (in mm)?
40/0/0 100.0 0.0
6� . . .how the vibration
parameters are measured, if
own settings are used?
44/5/2 86.3 3.9 . . .how the vibration
parameters are measured
34/3/3 85.0 7.5
7 . . .the definitions/explanations
of the vibration parameters?
41/3/7 80.4 13.7 . . .the definitions/
explanations of the vibration
parameters?
31/6/3 77.5 7.5
8 . . .which peak-acceleration (in
multiples of g) occurs?
41/7/3 80.4 5.9 . . .which peak-acceleration
(in multiples of g) occurs?
32/5/3 80.0 7.5
9 . . .the position of each foot on
the base of the vibration
platform to calculate PDD or
amplitude for side-alternating
vibration?
41/8/2 80.4 3.9 . . .the position of each foot on
the base of the vibration
platform to calculate PDD or
amplitude for side-alternating
vibration?
37/2/1 92.5 2.5
10� . . .the position of the platform
where PDD or amplitude is
measured?
41/9/1 80.4 2.0 Incorporated in item 14
11 . . .whether manufacturer
settings or own settings are
used?
40/5/6 78.4 11.8 . . .whether manufacturer
settings or own settings are
used?
34/2/4 87.5 5.0
12 . . .whether the vibration is
immediately full or increases
slowly?
40/6/5 78.4 9.8 . . .whether the vibration is
immediately full or increases
slowly?
34/3/3 85.0 10.0
13 . . .which peak-to-peak
displacement (PDD) of the
vibration occurs?
40/7/4 78.4 7.8 . . .which peak-to-peak
displacement (PDD) of the
vibration occurs?
33/5/2 85.0 7.5
14� . . .where on the platform the
vibration parameters are
measured, if own settings are
used?
38/10/3 74.5 5.9 . . .where on the platform the
vibration parameters are
measured?
35/3/2 82.5 5.0
15 . . .what the accuracy of
vibration parameters is?
35/12/4 68.6 7.8 . . .what the accuracy of
vibration parameters is?
22/13/5 55.0 12.5
16� . . .which acceleration (in
RMS) occurs?
19/20/12 37.3 23.5 . . .which acceleration occurs
based on a pilot study or
relevant literature?
13/18/9 32.5 22.5
Additional suggestions 27/24 a 52.9 47.1
Information about device Information about device
17 . . .whether the device vibrates
horizontal, vertical, side-
alternating, waveform
changing, or other?
50/0/1 98.0 2.9 . . .whether the device vibrates
horizontal, vertical, side-
alternating, waveform
changing, or other?
40/0/0 100.0 0.0
(Continued)
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Table 4. (Continued)
Round 1 Round 2
Item
Number
When considering human
studies using whole-body
vibration is it important to
report. . .
Rating
Yes/
Neutral/
No
Agreement
(% of yes)
Disagreement
(% of no)
When considering human
studies using whole-body
vibration is it important to
report. . .
Rating
Yes/
Neutral/
No
Agreement
(% of yes)
Disagreement
(% of no)
18 . . .whether changes are made
to the device (e.g. mounting a
chair on it)?
49/2/0 96.1 0.0 . . .whether changes are made
to the device (e.g. mounting a
chair on it)?
39/1/0 97.5 0.0
19 . . .the manufacturer, device
specifications, and production
type?
48/1/2 94.1 3.9 . . .the manufacturer, device
specifications, and production
type?
39/1/0 97.5 0.0
20 . . .whether a handrail is
available?
42/4/5 82.4 9.8 . . .whether a handrail is
available?
34/3/3 85.0 7.5
21 . . .how the energy is generated
(e.g. direct mechanical
transmission or
electromagnetic transmission)
as this can have an effect on
the performance of the device?
28/19/4 54.9 7.8 . . .how the energy is
generated (e.g. direct
mechanical transmission or
electromagnetic transmission)
as this can influence the
performance of the device?
20/12/8 50.0 20.0
22 . . .the size of the vibration
platform?
25/14/12 49.0 23.5 . . .the size of the vibration
platform?
17/10/13 42.5 32.5
Additional suggestions 9/42 a 17.6 82.4
Information about
administration
Information
about
administration
23 . . .which posture or body
position the participants take
on during the vibration (e.g.
sitting, standing, squatting)?
51/0/0 100.0 0.0 . . .which posture or body
position the participants take
on during the vibration (e.g.
sitting, standing, squatting)?
40/0/0 100.0 0.0
24 . . .whether the position/
posture changes during the
WBV (static versus dynamic
exercise)?
51/0/0 100.0 0.0 . . .whether the position/
posture changes during the
WBV (static versus dynamic
exercise)?
40/0/0 100.0 0.0
25 . . .the number of sessions
where WBV was utilized?
51/0/0 100.0 0.0 . . .the number of sessions
where WBV was utilized?
40/0/0 100.0 0.0
26 . . .the resting time between
sessions of WBV?
51/0/0 100.0 0.0 . . .the resting time between
sessions of WBV?
40/0/0 100.0 0.0
27 . . .the number of exposures to
WBV within one session?
50/1/0 98.0 0.0 . . .the number of exposures to
WBV within one session?
39/1/0 97.5 0.0
28 . . .where the feet of the
participants are placed?
49/2/0 96.1 0.0 . . .where the feet of the
participants are placed?
30/1/0 97.5 0.0
29 . . .the total exposure time to
WBV across all sessions?
48/1/2 94.1 3.9 . . .the total exposure time to
WBV across all sessions?
39/0/1 97.5 2.5
30 . . .where the hands of the
participants are placed?
47/3/1 92.2 2.0 . . .where the hands of the
participants are placed?
37/1/2 92.5 5.0
31 . . .which exact tools and aids
were used during the WBV
(e.g. type and size of
dumbbells)?
46/4/1 90.2 2.0 . . .which exact tools and aids
were used during the WBV
(e.g. type and size of
dumbbells)?
36/3/1 90.0 2.5
32 . . .the on vs. off-times of
vibration (e.g. pauses and how
long) within one session?
45/5/1 88.2 2.0 . . .the on vs. off-times of
vibration (e.g. pauses and how
long) within one session?
37/1/2 92.5 5.0
33 . . .whether an examiner was
present to supervise the WBV
administration?
43/3/5 84.3 9.8 . . .whether an examiner was
present to supervise the WBV
administration?
34/2/4 85.0 10.0
(Continued)
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Table 4. (Continued)
Round 1 Round 2
Item
Number
When considering human
studies using whole-body
vibration is it important to
report. . .
Rating
Yes/
Neutral/
No
Agreement
(% of yes)
Disagreement
(% of no)
When considering human
studies using whole-body
vibration is it important to
report. . .
Rating
Yes/
Neutral/
No
Agreement
(% of yes)
Disagreement
(% of no)
34� . . .whether the cognitive/
physical outcome measures are
assessed during or after the
WBV?
41/5/5 80.4 9.8 . . .whether the outcome
measures (cognitive/physical)
are assessed during or after
the WBV?
35/2/3 87.5 7.5
35 . . .possible follow-ups to
determine possible lasting
effects?
41/7/3 80.4 5.9 . . .possible follow-ups to
determine possible lasting
effects?
34/2/4 85.0 10.0
36 . . .how resonance (skidding of
feet) is prevented (e.g. front-
foot vs. mid-foot stance)?
39/9/3 76.5 5.9 . . .how resonance (skidding
of feet) is prevented (e.g.
front-foot vs. mid-foot
stance)?
27/8/5 67.5 12.5
37 . . .the location of the
intervention (e.g. hospital or
gym)?
30/8/13 58.8 25.5 . . .the location of the
intervention (e.g. hospital or
gym)?
28/7/5 70.0 12.5
38 . . .the conditions of the test
room (e.g. light and
temperature)?
24/10/17 47.1 33.3 . . .the conditions of the test
room (e.g. light and
temperature)?
20/6/14 50.0 35.0
Additional suggestions 10/41 a 19.6 80.4
Information about participants Information about
participants
39 . . .subjective experiences of
participants before, during, or
after the WBV (e.g. dizziness,
pain, postural instability,
muscle fatigue)?
46/4/1 90.2 2.0 . . .subjective experiences of
participants before, during, or
after the WBV (e.g. dizziness,
pain, postural instability,
muscle fatigue)?
37/1/2 92.5 5.0
40� . . .the participants’ BMI
(height, weight)?
45/2/4 88.2 7.8 . . .the participants’ height and
weight?
39/0/1 97.5 2.5
41 . . .the participants’ footwear
(shoes, socks, barefoot) during
WBV with a detailed
description?
45/4/2 88.2 3.9 . . .the participants’ footwear
(shoes, socks, barefoot)
during WBV with a detailed
description?
38/1/1 95.0 2.5
42 . . .if, how, and for how long
participants prepared for the
WBV (e.g. stretching, muscles,
warm up)?
43/6/2 84.3 3.9 . . .if, how, and for how long
participants prepared for the
WBV (e.g. stretching,
muscles, warm up)?
36/3/1 90.0 2.5
43 . . .the participants’ fitness and
activity levels?
43/7/1 84.3 2.0 . . .the participants’ fitness and
activity levels?
37/2/1 92.5 2.5
44 . . .how it is assured that neck
and head are not negatively
affected by the vibration?
33/10/8 64.7 15.7 . . .how it is assured that neck
and head are not negatively
affected by the vibration?
20/10/10 50.0 25.0
45 . . .the participants’ clothing
during the WBV?
24/12/15 47.1 29.4 . . .the participants’ clothing
during the WBV?
15/11/14 37.5 25.0
46 . . .skin and muscle perfusion
during the WBV?
16/15/20 31.4 39.2 . . .skin and muscle perfusion
during the WBV?
5/15/20 12.5 50.0
47 . . .whether possible glasses
were disturbing during the
vibration?
14/20/17 27.5 33.3 . . .whether possible glasses
were disturbing during the
vibration?
6/12/22 15.0 55.0
48 . . .whether the participants
wore glasses during WBV?
13/18/20 25.5 39.9 . . .whether the participants
wore glasses during WBV?
6/9/25 15.0 62.5
(Continued)
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First, it was suggested twice that surface electromyography (sEMG) should be included to
evaluate and record the electrical signals produced by muscle activity. Second, it was suggested
twice that the way the participants’ body mass might influence the vibration parameters should
be measured. It has further been suggested that this could be done by comparing the vibration
parameters of the empty vibration device and while a participant is using it. Third, it was sug-
gested once that the acceleration in ms-2 RMS should be reported. Fourth, it was suggested
that accelerations should be measured vertically and horizontally.
For information about the vibration, it was suggested twice that regardless of using own or
manufacturer settings (item 11), the vibration parameters should always be measured, as they
can be faulty. Therefore, several questions were added to the questionnaire of round 2. First,
whether it should be reported if manufacturer settings are used but additionally report own
vibration parameter measurement; second, whether it is sufficient to report manufacturer set-
tings without additional measurements; and third, whether vibration parameters should
always be measured regardless whether manufacturer settings are used or not.
For the second category information about the device some additional items were suggested.
Yet, they were judged to be unrelated to this category (see dataset for the comments) and thus
no additional questions from these comments were added to the questionnaire of round 2.
For information about the administration, two additional items were suggested. First,
reporting whether parts of the subjects are exposed to vibration in contrast to whole body
vibration (e.g., only the feet) was suggested twice. Second, it was suggested once to report the
decision which parts of the subjects are exposed to vibration and why.
For information about the participants two additional items were suggested. First, it was
commented three times that the training history of the subjects should be reported. Second, it
was suggested once to report the subjects’ history of injuries.
All comments and additional suggestions are included in the dataset.
Round 2
Sample characteristics. See Table 3 for an overview of the demographic characteristics of
the 40 panel members that completed round 2.
Integration of comments from round 1. In round 2, three of the items of the first round
were rephrased based on comments from the experts. Item 8 (report which acceleration occurs)
was rephrased to which acceleration occurs based on pilot study or relevant literature. Item 14
(where on the platform the vibration parameters are measured, if own settings are used) was
rephrased to where on the platform the vibration parameters are measured, since it was com-
mented by the expert panel that the vibration parameters have to be assessed since the infor-
mation of the manufacturers may be inaccurate. Item 10 (the position on the platform where
Table 4. (Continued)
Round 1 Round 2
Item
Number
When considering human
studies using whole-body
vibration is it important to
report. . .
Rating
Yes/
Neutral/
No
Agreement
(% of yes)
Disagreement
(% of no)
When considering human
studies using whole-body
vibration is it important to
report. . .
Rating
Yes/
Neutral/
No
Agreement
(% of yes)
Disagreement
(% of no)
Additional suggestions 10/41 a 19.6 80.4
Questions marked a had only yes/no answer options
� indicates a rephrasing of the item for the second round; bold indicates agreement of 70% or higher and no disagreement of 20% or higher; italic indicates a
disagreement of 20% or higher; the dotted box depicts the incorporation of item 10 into item 14.
https://doi.org/10.1371/journal.pone.0235905.t004
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Table 5. Round 2 ratings of the additionally suggested items of round 1.
Items [number of times suggested] Rating Yes/
Neutral/No
Agreement (% of
yes)
Disagreement (% of
no)
Additional items: Information about vibration
. . .always measure vibration parameters, even if manufacturer settings are used? [1x] 26/3/11 65.0 27.5
. . .the vertical and horizontal accelerations? [1x] 25/8/7 62.5 17.5
. . .how the subject’s body mass affects the vibration parameters (compare measure with and
without subject on the platform)? [2x]
24/5/11 60.0 27.5
. . .report whether manufacturer settings are used but additionally report own vibration parameter
measurements? [2x]
23/11/6 57.5 15.0
. . .the intensity of the exposure (in m/s^2 RMS)? [1x] 19/9/12 47.5 30.0
. . .if manufacturer settings are used, is it sufficient to report these? [1x] 19/6/15 47.5 37.5
. . .sEMGs (surface electromyography) to evaluate and record the electrical signals produced by
muscle activity [2x]
12/10/18 30.0 45.0
How should vibration parameters be measured?
. . .with frequency and amplitude [4x] 37/2/1 92.5 2.5
. . .with the aid of accelerometers [24x] 31/3/6 77.5 15.0
If yes: how should accelerometers be used? Count %
3D-accelerometer for vertical and horizontal acceleration 10 32.5
Accelerometer at vibration platform only 4 12.9
Accelerometer on participant only (e.g. at joints) 0 0.0
Accelerometer at vibration platform and on participant 14 45.2
It does not matter how they are measured, as long as they are measured 1 3.2
Other 2 6.5
. . .with frequency, amplitude, and peak-to-peak displacement [1x] 28/8/4 70.0 10.0
. . .with frequency and amplitude over time [1x] 19/13/8 47.5 20.0
Vibration parameters should be measured to the individual case [1x] 16/12/12 40.0 30.0
. . .with frequency and amplitude including RMS (in multiples of g) [1x] 15/13/12 37.5 30.0
. . .with peak-to-peak amplitude rather than RMS [1x] 14/17/9 35.0 22.5
It is not important how they are measured but that they are reported [1x] 12/8/20 30.0 50.0
. . .with laser Distance Sensor [2x] 6/19/15 15.0 37.5
. . .with gyroscope [1x] 4/19/17 10.0 42.5
Additional items: Information about administration
. . .to report whether only parts of the subjects’ body are subjected to vibration (e.g. only the feet)?
[2x]
33/4/3 82.5 7.5
. . .to explain the decision which parts (e.g. only feet) of the participants are subjected to vibration
and why [1x]
28/4/8 70.0 20.0
Additional items: Information about participants
. . .training history [3x] 33/4/3 82.5 10.0
. . .history of injuries [1x] 27/11/5 60.0 12.5
Which subjective experiences should be reported?
Side effects/adverse effects 40/0/0 100.0 0.0
Pain (location, intensity, type) 36/3/1 90.0 2.5
Dizziness 35/3/2 87.5 5.0
(Dis)comfort 33/4/3 82.5 7.5
Fatigue/exhaustion/tiredness 32/5/3 80.0 7.5
Tingling/itching/burning sensations 32/7/1 80.0 2.5
Perceived exertion/effort (e.g. with Borg RPE scale) 31/6/3 77.5 7.5
Muscle soreness/weakness 30/7/3 75.0 7.5
Headache 30/7/3 75.0 7.5
Loss of balance 29/7/4 72.5 10.0
(Continued)
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peak-to-peak displacement (PPD) or amplitude is measured) was rephrased due to comments of
the expert that the phrasing was not optimal. It was incorporated into item 14 since PDD and
amplitude are vibration parameters.
Agreement ratings. The results of the judgement on the pre-determined items which
were presented along with the ratings of the first round can be found in Table 4.
For items previously judged as important, agreement rates mostly increased in all four cate-
gories (see Table 4). For the first category information about the vibration the same items as in
the first round had an agreement of at least 70% and no disagreement over 20% (items 1–14
excluding item 10). For all, except four items (1, 2, 6, 7), the agreement rate increased. Simi-
larly to the first category, the second category information about the device also showed similar
ratings in round 2 as in round 1. Again, the items previously judged as important to report,
received higher agreement rates in the second round (items 17–20). Information about the
administration items were agreed upon for the same items (items 23–35 with an agreement of
70% or higher) of the first round. As depicted in Table 4, ratings of item 36 fell below the 70%
threshold and the ratings of item 37 increased. The same items regarding information about
the participants were agreed upon (items 39–43) in round 2 and the agreement-rate increased
for all.
The ratings of the additional suggested items and the responses of the open questions are
presented in Table 5. For the additional items concerning information about vibration, no item
was agreed-upon in terms of necessity of reporting. In the first round, the question how should
vibration parameters be measured? was answered by the experts. These answers were rated in
the second round (see Table 5). An agreement was established for the use of accelerometers
(77.5%), with frequency and amplitude (92.5%), and frequency, amplitude, and peak-to-peak
displacement (70%). Since various usages of accelerometers were suggested in the first round,
the experts were additionally asked to rate how the accelerometer should be used, if agreed to
it. The majority voted for the use of 3D-accelerometers on both participant and platform and
horizontally and vertically (see Table 5).
Two additional items were suggested for the information about the administration (see
Table 5). Both reached an agreement-rate of 70% or higher (82.5% and 70%). However, one of
these items also reached a disagreement-rate of 20% (see Table 5).
For the category information about the participants two suggestions were made in the first
round. The first suggestion was agreed-upon, while the second was not (see Table 5). Supple-
mentary to the additional suggestions, the answers of the open question of which subjective
experience should be reported were rated. Ten items were agreed upon and two were disagreed
upon (see Table 6).
Table 5. (Continued)
Items [number of times suggested] Rating Yes/
Neutral/No
Agreement (% of
yes)
Disagreement (% of
no)
Vertigo 26/8/6 65.0 15.0
Subjective experience depends on the aim of the study and cannot be generalized 25/9/6 62.5 15.0
Nausea 24/9/7 60.0 17.5
Redness 23/10/7 57.5 17.5
Enjoyment 19/10/11 47.5 27.5
Mood 18/12/10 45.0 25.0
Bold indicates agreement of 70% or higher and no disagreement of 20% or higher; italic indicates a disagreement of 20% or higher.
https://doi.org/10.1371/journal.pone.0235905.t005
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Table 6. Final list of aspects of human WBV studies after round 3 of this Delphi study.
Category Items
Information about vibration 1. The type of vibration (i.e., synchronous, side-alternating, other)
2. The units of the vibration parameters
3. The amplitude of the vibration (in mm)
4. Which frequency (Hz) is used
5. The position of each foot on the base of the vibration platform to calculate PDD or
amplitude for side-alternating vibration
6. Whether the frequency (Hz) is constant or variable
7. Whether manufacturer settings or own settings are used
8. How the vibration parameters are measured
9. Whether the vibration is immediately full or increases slowly
10. Which peak-to-peak displacement (PDD) of the vibration occurs
11. Where on the platform the vibration parameters are measured
12. Which peak-acceleration (in multiples of g) occurs
13. The definitions/explanations of the vibration parameters (see [1,6,23,32])
14. Vibration parameters should be measured with
• frequency and amplitude, or
• frequency, amplitude, and peak-to-peak displacement, or
• the aid of 3D-accelerometers
a. with 3D-accelerometer at vibration platform and on participant, and/or
b. 3D-accelerometer for vertical and horizontal acceleration
Information about device 15. >Whether the device vibrates horizontal, vertical, side-alternating, waveform
changing, or other)
16. Whether changes are made to the device (e.g., mounting a chair on it)
17. The manufacturer, device specifications, and production type
18. Whether a handrail is available
Information about
administration
19. Which posture or body position the participants take on during the vibration (e.g.,
sitting, standing, squatting)
20. Whether the position/posture changes during the WBV (static versus dynamic
exercise)
21. The number of sessions where WBV was utilized
22. The resting time between sessions of WBV
23. The number of exposures to WBV within one session
24. Where the feet of the participants are placed
25. The total exposure time to WBV across all sessions
26. Where the hands of the participants are placed
27. The on vs. off-times of vibration (e.g., pauses and how long) within one session
28. Which exact tools and aids were used during the WBV (e.g. type and size of
dumbbells)
29. Whether the outcome measures (cognitive/physical) are assessed during or after the
WBV
30. Whether an examiner was present to supervise the WBV administration
31. Possible follow-ups to determine possible lasting effects
32. To report whether only parts of the subjects’ body are subjected to vibration (e.g.,
only the feet)
33. The location of the intervention (e.g., hospital or gym)
34. To explain the decision which parts (e.g., only feet) of the participants are subjected
to vibration and why
(Continued)
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Table 6. (Continued)
Category Items
Information about
participants
35. The participants’ height and weight
36. The participants’ footwear (shoes, socks, barefoot) during WBV with a detailed
description
37. Subjective experiences of participants before, during, or after the WBV
• Side effects/adverse effects
• Pain
• Dizziness
• (Dis)comfort
• Fatigue/exhaustion/tiredness
• Tingling/itching/burning sensations
• Perceived exertion/effort (e.g., with Borg RPE scale)
• Muscle soreness/weakness
• Headache
• Loss of balance
38. The participants’ fitness and activity levels
39. If, how, and for how long participants prepared for the WBV (e.g., stretching, muscle
warm up)
40. Training history
Optional items 1. The vertical and horizontal accelerations
2. Which acceleration occurs based on a pilot study or relevant literature
3. Report whether manufacturer settings are used but additionally report own vibration
parameter measurements
4. What the accuracy of vibration parameters is
5. How resonance (skidding of feet) is prevented (e.g. front-foot vs. mid-foot stance)
6. How the subject’s body mass affects the vibration parameters (compare measure with
and without subject on the platform)
7. The intensity of the exposure (in m/s^2 RMS)
8. Always measure vibration parameters, even if manufacturer settings are used
9. If manufacturer settings are used, it is sufficient to report these
10. sEMGs (surface electromyography) to evaluate and record the electrical signals
produced by muscle activity
11. Measurements of vibration parameters:
a. With frequency and amplitude over time
b. Vibration parameters should be measured to the individual case
c. With frequency and amplitude including RMS (in multiples of g)
d. With peak-to-peak amplitude rather than RMS
e. It is not important how they are measured but that they are reported
12. How energy is generated (e.g. direct mechanical transmission or electromagnetic
transmission) as this may influence the performance of the device
13. The size of the vibration platform
14. The conditions of the test room (e.g. light and temperature)
15. Explain the decision which parts (e.g. only feet) of the participants are subjected to
vibration and why
16. Other subjective experiences
• Vertigo
• Nausea
• Redness
• Enjoyment
• Mood
17. History of injuries
18. How it is assured that neck and head are not negatively affected by the vibration
19. The participants’ clothing during the WBV
https://doi.org/10.1371/journal.pone.0235905.t006
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Round 3
Sample characteristics. See Table 3 for an overview of the demographic characteristics of
the 37 panel members that completed round 3.
Final agreements. The final, agreed-upon, list can be found in Table 6. Thirty-five of the
37 experts comprising the expert panel in the last round, agreed with this final list (agreement
of 94.6%). One of the experts disagreed with the subjective experiences of the list, without giving
further explanations. The second disagreement concerned the statement of ‘how vibration
parameters should be measured’ with the explanations that these recommendations are mutu-
ally exclusive, and it needs to be clarified whether 1D- or 3D-accelerometers should be utilized.
The statements of the two disagreeing experts can be found in the available dataset.
Discussion
The aim of the present study was to lay an empirical foundation for the first steps in the devel-
opment of reporting guidelines for all scientific disciplines applying WBV as a training or
treatment method to human subjects. This was based on the recommendations by the EQUA-
TOR Network [36] with a three-round Delphi method. As elaborated in the introduction, a
need for updating and extending the recommendations by Rauch et al. [1] was identified on
the grounds of creating the guidelines in a systematic fashion and the still persisting incom-
plete reporting and misunderstandings of terminology. The combination of these aspects may
hamper the comparability of studies, interferes with their replicability, and ultimately prevents
the achievement of pivotal insights into the effects of WBV. Therefore, the knowledge and
opinions of international experts working with WBV was collected and integrated.
The Delphi method is widely used due to its advantages. First, it can be applied to groups of
varying size [58]. Second, it is thought to minimize issues of collective decision making, such
as reciprocal influence and lack of anonymity [37] and, thus, prevents the imposition of opin-
ions from dominant individuals [59]. Third, with the Delphi method, the opinion of a large
number of individuals with diverse geographical and professional backgrounds is collectible.
Fourth, anonymity allows the participants to opinionate unpopular aspects and change their
responses [60]. Therefore, the utilization of the Delphi method appears appropriate to lay the
foundation for the reporting guidelines and as the methods of the present study.
Throughout this Delphi study, a “yes”/“no”/“neutral/don’t know” rating system is used.
The experts are asked to consider whether one specific item should be reported in a publica-
tion of a WBV study or not. Additionally, the experts are instructed to consider the whole field
of WBV, as opposed to personal studies, since the guidelines should be relevant for all applica-
tions of WVB. Thus, another rating system was judged to reduce the explanatory power of the
results due to a missing indication about the reasoning why an item was judged, for example
as “very important” compared to “important”.
In the next step, the executive group will use the generated list of the Delphi study to
develop the reporting guidelines, according to the EQUATOR Network [36] recommenda-
tions. Issues that will be considered are (1) modifications of items (e.g., rephrasing), (2) adding
further items deemed as important (e.g., define the boundaries of low and high frequency), (3)
discussing the comments of disagreeing experts and potential consequences for the guidelines,
(4) decide about the inclusion/exclusion of the optional items, and (5) the publication and dis-
semination strategy (e.g., register at EQUATOR Network).
The three rounds of the present study ensured that the expert panel was able to refine their
judgements about the pre-determined items, suggest additional items, and rate all items
repeatedly. A large consensus on the final list of aspects was established according to this Del-
phi study (94.6%). The results show high levels of consensus for various items, as judged by an
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agreement rate of 70% while the disagreement rate was below 20%. The items which attained
consensus were included in the final list (see Table 6).
Even though most items reached either an agreement or disagreement, some items were
left without consensus after the three rounds (i.e., no agreement of 70% or higher and no dis-
agreement of 20% or higher). We propose that these optional items could be individually con-
sidered for reporting as they can be valuable for particular studies. There are 19 optional items
(see Tables 3 and 4 for ratings). These items were disproportionally often rated as neutral com-
pared to items of consensus (see Tables 4 and 5). It can be speculated that either unfamiliarity
with the item or ambiguously posed questioning of the item were reason of reaching no con-
sensus. Since items were rephrased throughout the three rounds, ensuring proper and unam-
biguous phrasing, possible unfamiliarity with items is conceivable. Thus, considering the
optional items for future WBV studies and reporting is sensible depending on the study. The
final decision about these items will be completed by the executive group and reported on in
the new guidelines.
The identified items of the final list largely correspond to the advice given by previous pub-
lications concerning the terminology and vibration parameters [6,32] as well as the reporting
recommendations of WBV studies [1]. The aspects discussed by Lorenzen et al. [32] (i.e., mag-
nitude of vibration), which are commonly misused or misunderstood, are in line with the final
list of the present study. Similarly, the technical parameters discussed by Rittweger [6] corre-
spond to the first category (information about the vibration) of the final list. Deviating from
the final list, Rittweger [6] emphasized the physiological effects of WBV (e.g., EMG, skin and
muscle perfusion, safety concerns). Some of these aspects were included in the first round of
the present study (e.g., report how it is assured that neck and head are not negatively affected) or
were suggested by experts. However, these aspects did not reach consensus and were only
included in the optional list (see Tables 4 and 5).
While safety concerns have been given extensive consideration before [6,23], according to
the experts’ ratings, this information may not be generally applicable for WBV reporting
guidelines. Consideration of safety is, nevertheless, relevant for WBV study design and the
mentioned references may be consulted. However, this is a separate issue requiring more
attention and investigation. Thus, recommendations concerning safe parameter settings will
not be a part of the upcoming reporting guidelines.
One of the starting points for creating the initial included aspects for the Delphi study were
the recommendations by Rauch et al. [1]. Their suggestions are, with few exceptions, consis-
tent with the final list of the present study. Instead of the four categories of the present study,
Rauch and colleagues [1] recommend reporting aspects of two categories: (1) items related to
the WBV device and (2) items related to study participants.
All aspects discussed in their recommendations concerning the first category [1], except
skidding of feet (optional item), assessing skidding (not included), and changes in vibration
settings (not included), reached consensus in the present study. The aspect of changes in vibra-
tion settings may not be relevant for WBV research per se as (1) changes in the protocol of
studies should always be reported [34] and (2) reporting a-priori planned changes of vibration
parameters is an inherent part of item 4 (which frequency (Hz) is used; Table 6) and other
items specifying vibration parameters. Aspects of Rauch and colleagues’ second category [1],
which are not directly included in the present study are the explained difficulties related to
assessing vibration parameters on the body of participants. Yet, this is incorporated in item 14
of the final list (how vibration parameters should be measured; Table 6).
While the results of the present study are in accordance with the 13 recommendations by
the team around Rauch [1], the results add further 27 WBV-specific aspects to the recommen-
dations. For example, the information concerning participants and administrations, as well as
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more specifications concerning information about vibration and the device, such as where and
how the vibration parameters are measured. Therefore, the final list (1) is an update on previ-
ous recommendations, (2) extends beyond the category information about vibration, (3) is
approved by experts in the field, and (4) may, thus, serve as the foundation on which reporting
guidelines can be established upon.
Limitations
Based on its advantages and the aim of the study, the utilization of the Delphi method was con-
sidered appropriate in order to empirically identify items of importance for reporting guide-
lines of human WBV studies. Yet, some possible limitations must be acknowledged.
Regarding the response rate, of the 136 originally invited experts, 56 opened and started to
fill out the first questionnaire and 51 of these completed the questionnaire (41.2% of the
invited experts). However, it remains unclear why some invited experts participated in the
study while others did not. Thus, the possibility of non-response bias [61] is conceivable,
which may hamper the significance of our results. Plausible explanations for non-responses
include, but are not limited to, the reason that (1) invitation e-mails were filtered out by the
recipient e-mail providers, (2) the expert forgot to fill in the questionnaire despite reminders,
(3) the time requirement of participation was too high, (4) the experts were too occupied, (5)
the expert may not render the study as relevant, (6) the potential panel member felt they were
lacking expertise, and/or (7) one expert participated on behalf of their research team. Since the
reasons for non-response have not been investigated, the possible bias on the results cannot be
determined. These considerations also apply to the drop-out over the three rounds since it
remains unclear why some experts did not continue to be part of the expert panel. The demo-
graphic data of the participants over the three rounds indicates that experts from various geo-
graphical and academic backgrounds did not participate in subsequent surveys. There is,
however, an indication that more physical therapists from Brazil dropped out (42% of overall
drop-out) and dropped out panel members who are physical therapists had either a M.Sc. (2 of
7) or PhD (5 of 7). These observations could indicate a potential bias. Possible explanations
could be, but are not limited to, that physical therapists in Brazil (1) have a higher work-load
and, thus, less time to respond to the surveys in comparison to the other experts; (2) deem the
commencement of reporting guidelines unnecessary; (3) respond for a research team more
frequently; (4) felt they have less expertise to answer the questions; or (5) judge the topic irrele-
vant for their field. The explanations of drop-out cannot be (dis)proven without contacting
these experts. However, the drop-out led to only very slight changes in age, experience rate,
number of published studies and the other demographic information. Notwithstanding, 72.5%
of the 51 experts of the first round participated in the study until the end and continued to be
part of the panel and measures were taken to reduce the drop-out rate (i.e., reminder e-mails).
This rate is sufficient to achieve a valid Delphi process [62,63].
The second limitation of the Delphi method and the present study is the arbitrary determi-
nation of a consensus rate. There is no agreed-upon consensus definition in the scientific liter-
ature and is defined differently in various studies utilizing this method ranging from an
agreement rate of 51% to 100% [37,39,46]. The rational of the boundary conditions for the
present study was based on the probable unattainability of an extremely high agreement rate
(e.g., 100%), yet the agreement should be considerably higher than 50%. The disagreement
condition was introduced to ensure that an item is not accepted in case of diverging opinions,
i.e., if there are substantial numbers of experts agreeing but also disagreeing or a high number
of experts refrain from giving a definite rating (i.e., choose “neutral/don’t know”). Items with-
out consensus were not disregarded but suggested as optional items. Thus, some items that
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may be important are not omitted entirely but the reader has the chance to make his or her
own evaluation.
Based on the evolving field of WBV research and the limitations of the present study, future
research may potentially re-evaluate and update the presented list once the reporting guide-
lines have been established.
Strengths
The expertise and knowledge of the panel is one of the main determinants of the validity of the
study [39]. If expertise is limited, the results may not reflect the opinion of the scientific com-
munity and important aspects may be neglected. One indication of expertise are the character-
istics of the panel. For the present study, the characteristics of the experts indicate that they
indeed created a panel with expertise and valuable insights in the utilization of WBV, even
when considering drop-out. With most panel members having a doctor title (57%) or being a
professor (41%), the academic level of the experts was high. Also, the number of publications
(M = 11.6 in round 3) and years of experience with WBV in research (M = 19.4 in round 3)
and clinical settings (M = 11.6 in round 3) supports the presence of expertise. The inclusion of
experts from various geographic locations and academic backgrounds further points to a het-
erogeneous, experienced expert panel, which increases the quality of responses, as more alter-
natives are likely to be considered [39,64]. Even though the panel appears to consist of experts
of WBV research, their level of expertise of all aspects of WBV may vary. This may explain the
high neutrality ratings of the items of no consensus (Tables 4 and 5).
Small panel sizes and response rates may distort validity of the results of a Delphi study.
There is little data on panel size and its effect on validity of reaching consensus [64]. Yet, the
reliability is thought to increase with panel size, while differences may be small with a panel of
more than 12 experts [64]. The present study included 37 to 51 experts, exceeding this advised
minimum group size. Additionally, the experts’ characteristics remained diverse regarding
age, gender, and geographic location throughout the rounds. One may therefore conclude that
the panel size was adequate to collect information and base conclusions on the panel’s exper-
tise [37].
Conclusion
The present study aimed to commence the establishment of reporting guidelines for human
WBV studies based on an empirical inquiry. A list of 40 aspects which were judged to be
important in reporting WBV studies (94.6% agreement of the expert panel) was created. This
study represents and includes a wide range of experts from various academic and geographic
backgrounds and extends the literature to aspects of other important categories, such as infor-
mation about the administration. Thus, the study adds to the existing literature by creating a
list of approved-upon items. Furthermore, the guidelines that will be based on the study will
extend the general reporting guidelines (e.g., CONSORT statement [34]) for clinical trials and
acts as an addition to it. The need of the reporting guidelines, the high agreement on the final
list, generally praising comments from the experts, and a low drop-out rate indicate the rele-
vance and importance of the present study.
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